Author

Michel Thépaut

Centre National de la Recherche ScientifiqueORCID 0000-0003-4792-8271Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biophysics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:E. coli· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Franck FieschiiD· 2 shared Agnes L. Hipgrave EderveeniD· 1 shared Alexandre StellaiD· 1 shared Antonio MolinaroiD· 1 shared Aurélie Bally· 1 shared Benjamin B. A. RaymondiD· 1 shared Cédric LaguriiD· 1 shared Frédéric LagarrigueiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

Franck FieschiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Lipopolysaccharides nanodiscs, a biomimetic platform to study bacterial surface.

Massilia Abbas, Samantha Micciulla, Jean‐Marie Teulon, Meriem Maalej, Macha Trembley, Roberta Marchetti, Antonio Molinaro, Michel Thépaut, Franck Fieschi, Jean‐Luc Pellequer, Cédric Laguri

This study develops LPS nanodiscs using SMA copolymers to investigate bacterial surface interactions and immune responses.

bioRxiv · Feb 5, 2025 · PreprintBiophysics

The human and mouse dendritic cell receptor DCIR binds to LRP1 N-glycans containing terminal galactoses, including the α-Gal antigen

Benjamin B. A. Raymond, Tamara Sneperger, Stella Rousset, Nelly Gilles, Aurélie Bally, Alexandre Stella, Agnes L. Hipgrave Ederveen, Julien Marcoux, Giulia Trimaglio, Michel Thépaut, Frédéric Lagarrigue, Odile Burlet‐Schiltz, Manfred Wuhrer, Franck Fieschi, Pascal Demange, , Yoann Rombouts

This study identifies LRP1 N-glycans with terminal galactoses as ligands for DCIR, revealing its specificity in immune regulation and potential therapeutic applications.

bioRxiv · May 20, 2024 · PreprintImmunology